ClinicalTrials.govpublic full text
Phase II Trial of Lu-177 FAP-2286 in Patients With Carcinoma of Unknown Primary
cancer of unknown primary, 177lu-fap-2286, ga-fapi-46, theranostic, fap-2286, fibroblast activation protein (fap), cancer-associated fibroblasts (caf), radiopharmaceutical, targeted radioligand therapy (trt), targeted radionuclide therapy, peptide-targeted radioligand therapy (ptrt), peptide receptor radionuclide therapy (prrt)
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 897677
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.